Home World News FDA Grants Accelerated Approval to Zanidatamab-hrii for Patients with Previously Treated Unresectable...

FDA Grants Accelerated Approval to Zanidatamab-hrii for Patients with Previously Treated Unresectable or Metastatic HER2-positive Biliary Tract Cancer

December 17, 2024

449

Evidence for efficacy is based on the results from the HERIZON-BTC-01 study